{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T09:38:52Z","timestamp":1777887532557,"version":"3.51.4"},"reference-count":41,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100008005","name":"Yonsei University College of Medicine","doi-asserted-by":"publisher","award":["6-2020-0225"],"award-info":[{"award-number":["6-2020-0225"]}],"id":[{"id":"10.13039\/501100008005","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100014188","name":"Ministry of Science and ICT, South Korea","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100014188","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100017317","name":"Catholic Medical Center","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100017317","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["2021R1C1C1005930"],"award-info":[{"award-number":["2021R1C1C1005930"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","physicamedica.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Physica Medica"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.ejmp.2026.105751","type":"journal-article","created":{"date-parts":[[2026,2,20]],"date-time":"2026-02-20T07:51:15Z","timestamp":1771573875000},"page":"105751","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Personalized survival models for choosing irradiated tumor burden on combined radiotherapy and immune checkpoint inhibitors in stage IV NSCLC patients"],"prefix":"10.1016","volume":"143","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0496-9962","authenticated-orcid":false,"given":"Yeseul","family":"Kim","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joongyo","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7005-8692","authenticated-orcid":false,"given":"Ibrahim","family":"Chamseddine","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4425-4489","authenticated-orcid":false,"given":"Clemens","family":"Grassberger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hong In","family":"Yoon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kyung Hwan","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yeona","family":"Cho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0172-0646","authenticated-orcid":false,"given":"Wonmo","family":"Sung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmp.2026.105751_b0005","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1016\/j.ijrobp.2013.08.035","article-title":"Combinations of radiation therapy and immunotherapy for melanoma: a review of clinical outcomes","volume":"88","author":"Barker","year":"2014","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ejmp.2026.105751_b0010","doi-asserted-by":"crossref","unstructured":"DeNardo GL, Sysko V V., DeNardo SJ. Cure of incurable lymphoma. Int J Radiat Oncol Biol Phys. 2006 Oct 1;66(SUPPL. 2).","DOI":"10.1016\/j.ijrobp.2006.06.038"},{"key":"10.1016\/j.ejmp.2026.105751_b0015","doi-asserted-by":"crossref","unstructured":"Labani-Motlagh A, Ashja-Mahdavi M, Loskog A. The Tumor Microenvironment: A Milieu Hindering and Obstructing Antitumor Immune Responses. Vol. 11, Frontiers in Immunology. Frontiers Media S.A.; 2020.","DOI":"10.3389\/fimmu.2020.00940"},{"issue":"2","key":"10.1016\/j.ejmp.2026.105751_b0020","doi-asserted-by":"crossref","first-page":"66","DOI":"10.14407\/jrpr.2018.43.2.66","article-title":"Effects of Tumor Microenvironmental Factors on DNA Methylation and Radiation Sensitivity in A549 Human Lung Adenocarcinoma","volume":"43","author":"Oh","year":"2018","journal-title":"Journal of Radiation Protection and Research"},{"issue":"3","key":"10.1016\/j.ejmp.2026.105751_b0025","first-page":"209","article-title":"Global Cancer Statistics 2020: GLOBOCAN estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.ejmp.2026.105751_b0030","doi-asserted-by":"crossref","unstructured":"Lemjabbar-Alaoui H, Hassan OUI, Yang YW, Buchanan P. Lung cancer: Biology and treatment options. Vol. 1856, Biochimica et Biophysica Acta - Reviews on Cancer. Elsevier B.V.; 2015. p. 189\u2013210.","DOI":"10.1016\/j.bbcan.2015.08.002"},{"issue":"22","key":"10.1016\/j.ejmp.2026.105751_b0035","doi-asserted-by":"crossref","first-page":"2078","DOI":"10.1056\/NEJMoa1801005","article-title":"Pembrolizumab plus Chemotherapy in Metastatic Non\u2013Small-Cell Lung Cancer","volume":"378","author":"Gandhi","year":"2018","journal-title":"N Engl J Med"},{"issue":"22","key":"10.1016\/j.ejmp.2026.105751_b0040","doi-asserted-by":"crossref","first-page":"2093","DOI":"10.1056\/NEJMoa1801946","article-title":"Nivolumab plus Ipilimumab in Lung Cancer with a High Tumor Mutational Burden","volume":"378","author":"Hellmann","year":"2018","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.ejmp.2026.105751_b0045","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1080\/0284186X.2018.1554259","article-title":"Rationale for combination of radiation therapy and immune checkpoint blockers to improve cancer treatment","volume":"58","author":"Dahl","year":"2019","journal-title":"Acta Oncol (Madr)"},{"issue":"2","key":"10.1016\/j.ejmp.2026.105751_b0050","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1080\/0284186X.2020.1854851","article-title":"Immune checkpoint blockade in the treatment of advanced non-small cell lung cancer\u2013predictors of response and impact of previous radiotherapy","volume":"60","author":"\u00d6jlert","year":"2021","journal-title":"Acta Oncol (Madr)"},{"key":"10.1016\/j.ejmp.2026.105751_b0055","doi-asserted-by":"crossref","unstructured":"Rolfo C, Caglevic C, Santarpia M, Araujo A, Giovannetti E, Gallardo CD, et al. Immunotherapy in NSCLC: A promising and revolutionary weapon. In: Advances in Experimental Medicine and Biology. Springer New York LLC; 2017. p. 97\u2013125.","DOI":"10.1007\/978-3-319-53156-4_5"},{"key":"10.1016\/j.ejmp.2026.105751_b0060","doi-asserted-by":"crossref","unstructured":"Spaas M, Sundahl N, Kruse V, Rottey S, De Maeseneer D, Duprez F, et al. Checkpoint Inhibitors in Combination With Stereotactic Body Radiotherapy in Patients With Advanced Solid Tumors: The CHEERS Phase 2 Randomized Clinical Trial. JAMA Oncol [Internet]. 2023 Jul 6; Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/37410476.","DOI":"10.1001\/jamaoncol.2023.2132"},{"key":"10.1016\/j.ejmp.2026.105751_b0065","doi-asserted-by":"crossref","DOI":"10.1016\/S0140-6736(23)01384-3","article-title":"Stereotactic ablative radiotherapy with or without immunotherapy for early-stage or isolated lung parenchymal recurrent node-negative non-small-cell lung cancer: an open-label, randomised, phase 2 trial","author":"Chang","year":"2023","journal-title":"Lancet"},{"issue":"24","key":"10.1016\/j.ejmp.2026.105751_b0070","doi-asserted-by":"crossref","first-page":"2342","DOI":"10.1056\/NEJMoa1809697","article-title":"Overall Survival with Durvalumab after Chemoradiotherapy in Stage III NSCLC","volume":"379","author":"Antonia","year":"2018","journal-title":"N Engl J Med"},{"issue":"8","key":"10.1016\/j.ejmp.2026.105751_b0075","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2022.24478","article-title":"Immunotherapy after Chemotherapy and Radiation for Clinical Stage III Lung Cancer","volume":"5","author":"Pichert","year":"2022","journal-title":"JAMA Netw Open"},{"issue":"1","key":"10.1016\/j.ejmp.2026.105751_b0080","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2022.49591","article-title":"Analysis of Tumor Mutational Burden, Progression-Free Survival, and Local-Regional Control in Patents with locally Advanced Non-Small Cell Lung Cancer Treated with Chemoradiation and Durvalumab","volume":"6","author":"Lebow","year":"2023","journal-title":"JAMA Netw Open"},{"issue":"6","key":"10.1016\/j.ejmp.2026.105751_b0085","doi-asserted-by":"crossref","first-page":"2276","DOI":"10.1007\/s13346-021-00923-8","article-title":"Overcoming biological barriers to improve solid tumor immunotherapy","volume":"11","author":"Ukidve","year":"2021","journal-title":"Drug Deliv Transl Res"},{"issue":"4","key":"10.1016\/j.ejmp.2026.105751_b0090","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1080\/0284186X.2021.2023213","article-title":"Clinical features affecting efficacy of immune checkpoint inhibitors in pretreated patients with advanced NSCLC: a danish nationwide real-world study","volume":"61","author":"Mouritzen","year":"2022","journal-title":"Acta Oncol (Madr)"},{"issue":"5","key":"10.1016\/j.ejmp.2026.105751_b0095","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1016\/j.ijrobp.2019.08.047","article-title":"Impact of Treatment-Related Lymphopenia on Immunotherapy for Advanced Non-Small Cell Lung Cancer","volume":"105","author":"Cho","year":"2019","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"168","key":"10.1016\/j.ejmp.2026.105751_b0100","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.radonc.2022.01.007","article-title":"Lymphocyte dynamics during and after chemo-radiation correlate to dose and outcome in stage III NSCLC patients undergoing maintenance immunotherapy","volume":"1","author":"Cho","year":"2022","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ejmp.2026.105751_b0105","unstructured":"Kang C.M. Chung H.C. CCKJHJKYHSCYPMYLYSLSJJYHLDHYSYLDHCSYKTH. Calibration Curves for Biological Dosimetry by Drug-induced Prematurely Condensed Chromosomes in Human Lymphocytes. J Radiat Prot Res [Internet]. 2002;27(4):249\u201355. Available from: http:\/\/www.jrpr.org\/journal\/view.php?number=1082."},{"issue":"1","key":"10.1016\/j.ejmp.2026.105751_b0110","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1007\/s00415-019-09557-w","article-title":"Risk factors for lymphopenia in patients with relapsing\u2013remitting multiple sclerosis treated with dimethyl fumarate","volume":"267","author":"Morales","year":"2020","journal-title":"J Neurol"},{"key":"10.1016\/j.ejmp.2026.105751_b0115","unstructured":"Lundberg SM, Allen PG, Lee SI. A Unified Approach to Interpreting Model Predictions [Internet]. Available from: https:\/\/github.com\/slundberg\/shap."},{"key":"10.1016\/j.ejmp.2026.105751_b0120","article-title":"Regression Models and Life-Tables","volume":"34","author":"Cox","year":"1972","journal-title":"J Roy Stat Soc: Ser B (Methodol)"},{"issue":"3","key":"10.1016\/j.ejmp.2026.105751_b0125","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1214\/08-AOAS169","article-title":"Random survival forests","volume":"2","author":"Ishwaran","year":"2008","journal-title":"Annals of Applied Statistics"},{"key":"10.1016\/j.ejmp.2026.105751_b0130","doi-asserted-by":"crossref","unstructured":"Altman N, Krzywinski M. Points of Significance: Ensemble methods: Bagging and random forests. Vol. 14, Nature Methods. Nature Publishing Group; 2017. p. 933\u20134.","DOI":"10.1038\/nmeth.4438"},{"key":"10.1016\/j.ejmp.2026.105751_b0135","doi-asserted-by":"crossref","DOI":"10.1214\/aos\/1013203451","article-title":"GREEDY FUNCTION APPROXIMATION: a GRADIENT BOOSTING MACHINE 1","volume":"Vol. 29","author":"Friedman","year":"2001","journal-title":"The Annals of Statistics"},{"key":"10.1016\/j.ejmp.2026.105751_b0140","unstructured":"https:\/\/github.com\/Laurae2\/CategoricalAnalysis."},{"issue":"4","key":"10.1016\/j.ejmp.2026.105751_b0145","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1002\/(SICI)1097-0258(19960229)15:4<361::AID-SIM168>3.0.CO;2-4","article-title":"Multivariable prognostic models: issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors","volume":"15","author":"Harrell","year":"1996","journal-title":"Stat Med"},{"key":"10.1016\/j.ejmp.2026.105751_b0150","first-page":"7","article-title":"Bias in error estimation when using cross-validation for model selection","volume":"23","author":"Varma","year":"2006","journal-title":"BMC Bioinf"},{"key":"10.1016\/j.ejmp.2026.105751_b0155","first-page":"183","article-title":"Prognosis prediction for glioblastoma multiforme patients using machine learning approaches: Development of the clinically applicable model","volume":"1","author":"Kim","year":"2023","journal-title":"Radiother Oncol"},{"issue":"6","key":"10.1016\/j.ejmp.2026.105751_b0160","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.21037\/tlcr.2019.11.07","article-title":"Evaluation of the lung immune prognostic index in advanced nonsmall cell lung cancer patients under nivolumab monotherapy","volume":"8","author":"Ruiz-Ba\u00f1obre","year":"2019","journal-title":"Transl Lung Cancer Res"},{"key":"10.1016\/j.ejmp.2026.105751_b0165","doi-asserted-by":"crossref","unstructured":"Luke JJ, Lemons JM, Karrison TG, Pitroda SP, Melotek JM, Zha Y, et al. JOURNAL OF CLINICAL ONCOLOGY Safety and Clinical Activity of Pembrolizumab and Multisite Stereotactic Body Radiotherapy in Patients With Advanced Solid Tumors. J Clin Oncol [Internet]. 2018;36:1611\u20138. Available from: https:\/\/doi.org\/10.1200\/JCO.2017.","DOI":"10.1200\/JCO.2017.76.2229"},{"key":"10.1016\/j.ejmp.2026.105751_b0170","doi-asserted-by":"crossref","unstructured":"Ott PA, Bang YJ, Berton-Rigaud D, Elez E, Pishvaian MJ, Rugo HS, et al. JOURNAL OF CLINICAL ONCOLOGY Safety and Antitumor Activity of Pembrolizumab in Advanced Programmed Death Ligand 1-Positive Endometrial Cancer: Results From the KEYNOTE-028 Study. 2017 Aug 1; Available from: https:\/\/doi.org\/10.1200\/JCO.2017.","DOI":"10.1097\/01.ogx.0000527579.58363.20"},{"key":"10.1016\/j.ejmp.2026.105751_b0175","first-page":"123","article-title":"Time to abandon single-site irradiation for inducing abscopal effects. Nature Reviews Clinical Oncology","volume":"16","author":"Brooks","year":"2019","journal-title":"Nat Publ Group"},{"key":"10.1016\/j.ejmp.2026.105751_b0180","doi-asserted-by":"crossref","unstructured":"Nakamura N, Kusunoki Y, Akiyama M. Radiosensitivity of CD4 or CD8 Positive Human T-Lymphocytes by an in Vitro Colony Formation Assay. Vol. 123, Source: Radiation Research. 1990.","DOI":"10.2307\/3577549"},{"issue":"151","key":"10.1016\/j.ejmp.2026.105751_b0185","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.radonc.2020.07.025","article-title":"A tumor-immune interaction model for hepatocellular carcinoma based on measured lymphocyte counts in patients undergoing radiotherapy","volume":"1","author":"Sung","year":"2020","journal-title":"Radiother Oncol"},{"issue":"4","key":"10.1016\/j.ejmp.2026.105751_b0190","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1016\/j.ijrobp.2021.11.008","article-title":"Mathematical Modeling to Simulate the effect of adding Radiation Therapy to Immunotherapy and Application to Hepatocellular Carcinoma","volume":"112","author":"Sung","year":"2022","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ejmp.2026.105751_b0195","doi-asserted-by":"crossref","unstructured":"Williamson CW, Sherer M V., Zamarin D, Sharabi AB, Dyer BA, Mell LK, et al. Immunotherapy and radiation therapy sequencing: State of the data on timing, efficacy, and safety. Vol. 127, Cancer. John Wiley and Sons Inc; 2021. p. 1553\u201367.","DOI":"10.1002\/cncr.33424"},{"key":"10.1016\/j.ejmp.2026.105751_b0200","article-title":"Janeway\u2019s immunobiology","author":"Murphy","year":"2016","journal-title":"Garland science"},{"issue":"2","key":"10.1016\/j.ejmp.2026.105751_b0205","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/S1470-2045(14)71207-0","volume":"16","author":"Bradley","year":"2015","journal-title":"Lancet Oncol"}],"container-title":["Physica Medica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1120179726000384?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1120179726000384?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T04:16:05Z","timestamp":1777608965000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1120179726000384"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":41,"alternative-id":["S1120179726000384"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmp.2026.105751","relation":{},"ISSN":["1120-1797"],"issn-type":[{"value":"1120-1797","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Personalized survival models for choosing irradiated tumor burden on combined radiotherapy and immune checkpoint inhibitors in stage IV NSCLC patients","name":"articletitle","label":"Article Title"},{"value":"Physica Medica","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmp.2026.105751","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Associazione Italiana di Fisica Medica e Sanitaria. Published by Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"105751"}}